In situ click chemistry generation of cyclooxygenase-2 inhibitors.

Bhardwaj A, Kaur J, Wuest M, Wuest F. · 2017

Read In situ click chemistry generation of cyclooxygenase-2 inhibitors. by Bhardwaj A, Kaur J, Wuest M, Wuest F. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5431875.txt.

Description

Bhardwaj and co-authors let an enzyme build its own blocker inside its active site. Their research article appeared in Nature Communications. The enzyme is cyclooxygenase-2, or COX-2. It drives inflammation and shows up in several cancers. Its sibling COX-1 does housekeeping work the body needs. The two are so alike that selective drugs are hard to design. Past selective drugs carried heart risks. Some were withdrawn from sale.

The team used a method called in situ click chemistry. They fed the COX-2 active site a pool of building blocks. The enzyme picked the blocks that fit it best. Those blocks linked into a tight-binding inhibitor. Tests showed the enzyme chose wisely. Two new compounds came out of the screen. Both blocked COX-2 strongly and selectively. In living animals they calmed inflammation better than common COX-2 drugs. The approach may suit other hard drug targets.

Catalog record

CREATORBhardwaj A, Kaur J, Wuest M, Wuest F.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE53 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5431875

Browse the full library · About the Tower of Babel